Abstract
Fibrillary glomerulonephritis (FGN) is a rare cause of glomerulonephritis with poor prognosis. No standard treatment exists. We report a case of crescentic FGN presenting as rapidly progressing renal failure needing hemodialysis and treated based on Euro lupus nephritis trial protocol of low dose cyclophosphamide and glucocorticoid for induction followed by azathioprine maintenance. Patient responded very well to this therapy and was able to get off hemodialysis and continues with stable stage 3 CKD after 1 year follow up.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
